The Aporia
Howe, M. (2026, September 22). Simple test could ‘transform care’ for thousands of women with suspected womb cancer. Evening Standard. https://www.standard.co.uk/news/health/test-health-women-suspected-womb-cancer-university-manchester-b1297993.html
Howe, Megan. “Simple test could ‘transform care’ for thousands of women with suspected womb cancer.” Evening Standard, 22 Sept. 2026, https://www.standard.co.uk/news/health/test-health-women-suspected-womb-cancer-university-manchester-b1297993.html.
Howe, Megan. “Simple test could ‘transform care’ for thousands of women with suspected womb cancer.” Evening Standard, September 22, 2026. https://www.standard.co.uk/news/health/test-health-women-suspected-womb-cancer-university-manchester-b1297993.html.
Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.
Professor Emma Davidson from the University of Manchester and honorary consultant in gynaecological oncology at MFT has developed a new test that could "transform care" for thousands of women each year who experience postmenopausal bleeding. This symptom currently triggers urgent cancer referrals, leading to invasive tests like ultrasounds, biopsies, and hysteroscopies, which are often unnecessary since only 5% to 10% of these women have cancer. The new test, detailed in a study published in the Lancet Obstetrics, Gynaecology and Women’s Health, examines cells collected from urine and vaginal fluid samples provided by patients before routine tests. Among 1,864 women tested, the approach correctly identified 80% of cancers while having a negative predictive value of 98.8%, meaning those with a negative result are highly unlikely to have cancer. This development could reduce patient discomfort and healthcare costs associated with unnecessary invasive procedures.